Aptose Biosciences Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Lease Liability

Note 8 - Lease Liability

9 Months Ended

Sep. 30, 2024

Lease liability:

Aptose leases office space in San Diego, California. The lease for the San Diego office space is scheduled to expire in May 31, 2026. We leased office space in Toronto, Ontario, Canada, which lease expired on June 30, 2024. The Company has not included any extension periods in calculating its right-to-use assets and lease liabilities. The Company also enters into leases for small office equipment.

Minimum payments, undiscounted, under our operating leases are as follows:


Years ending December 31,
2024	$	113
2025		462
2026		197
Total	$	772

The following table presents the weighted average remaining term of the leases and the weighted average discount rate:


	September 30, 2024			December 31, 2023
Weighted-average remaining term – operating leases (years)		1.7			2.4
Weighted-average discount rate – operating leases		7.90	%		7.38	%

Lease liability, current portion	$	416		$	394
Lease liability, long-term portion		305			621
Total	$	721		$	1,015

Operating lease costs and operating cash flows from our operating leases are as follows:


	Three months ended September 30,				Nine months ended September 30,
	2024		2023		2024		2023
Operating lease cost	$	107	$	114	$	331	$	359
Operating cash flows from operating leases	$	112	$	117	$	346	$	290